/

Spyre Therapeutics

Developing long-acting antibody therapeutics for inflammatory bowel disease.

BiotechnologyPharmaceuticals spyre.com ↗

Company facts

Founded: 2013
Employees: 100
Headquarters: United States
Type: Public
Listed: NASDAQ: SYRE